Patent 7816406 was granted and assigned to Cylene Pharmaceuticals on October, 2010 by the United States Patent and Trademark Office.
The present invention provides quinolone analogs which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing quinolone analogs, and methods of using the same.